The HIV Advanced Disease Consortium

[The HIV Advanced Disease Consortium @hivadc]

Advanced HIV Disease: Who is Vulnerable?

https://t.co/I3BMHDeOkQ

#HIVAdvancedDisease #AdvancedHIVDisease

[The HIV Advanced Disease Consortium @hivadc]

Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy

https://t.co/NSKDFy1Gu3

#AdvancedHIVdisease #HIVAdvancedDisease

[MSF Access @MSF_access]

On #WorldAIDSDay we would like to remind @GileadSciences about its promise to expand access to lifesaving drug for people living with HIV.

We are still waiting... #GileadKeepYourPromise 👇
https://t.co/RaU2X2DZj4

[MSF Access @MSF_access]

Although @GileadSciences publicised their pledge to reduce the price of the drug L-AmB to a ‘no-profit’ price of US$16.25 per vial in September 2018, the drug continues to be mostly unavailable or priced out of reach in developing countries.

Read more 👉https://t.co/cStPeBCoxn

[MSF Access @MSF_access]

“Nothing more than a public relations stunt.”

@GileadSciences has failed to deliver on promises to make an important drug available to people living with #HIV
#GileadKeepYourPromise

👉 https://t.co/S80xiC7xhk

[MSF Access @MSF_access]

#WorldAidsDay #WAD2019
Over a year ago @GileadSciences promised to make an important #AIDS drug available to the world’s poorest countries.

Here is what Gilead has done instead ⬇️
https://t.co/T511wYbDYv

[MSF Access @MSF_access]

Over a year ago, @GileadSciences promised to make this long-awaited medicine for advanced HIV available for $16 in the countries that need it most. #WAD2019

In Sub-saharan Africa, where most people with HIV live, only TWO countries have the drug 👇 https://t.co/PesiJlZrPl

[MSF Access @MSF_access]

#WAD2019 #WorldAidsDay

At the current prices and with a recommended treatment that requires 21 vials for Ambisome, the total price of this HIV medicine rises to $4,200 for people in South Africa and $2,226 in India #GileadKeepYourPromise
👉 https://t.co/30FZO149mR

[The HIV Advanced Disease Consortium @hivadc]

@MSF findings on the current status of Advanced HIV Disease guidelines, funding and implementation in 15 countries.

https://t.co/6saZ0aYEyG

#HIVAdvancedDisease #AdvancedHIVDisease

[The HIV Advanced Disease Consortium @hivadc]

@MSF’s new model of care aims to reduce deaths among advanced HIV patients.

https://t.co/EF7N8BvlbA

[The HIV Advanced Disease Consortium @hivadc]

Half of all women with HIV in Europe are diagnosed at a late stage of HIV infection.

https://t.co/LGHS8h7oz8

[The HIV Advanced Disease Consortium @hivadc]

Algorithm-guided empirical tuberculosis treatment for people with advanced HIV.

https://t.co/TEXsmxVUnc

[The HIV Advanced Disease Consortium @hivadc]

Diagnostics sensitivity of SILVAMP TB-LAM.

https://t.co/iy9BLy1qWl

[The HIV Advanced Disease Consortium @hivadc]

Cochrane Review of TB LAM for PLHIV

https://t.co/wBhYMrQUqT

[Cambridge Nutritional Sciences Plc @CNS_PLC]

We’re excited to announce that the VISITECT® CD4 Advanced Disease, rapid test for supporting the identification of advanced disease in people living with HIV, has been assessed by the ERPD and is eligible for procurement with Global Fund or Unitaid funds.

[The HIV Advanced Disease Consortium @hivadc]

Flucytosine (5FC) needs to be registered in all countries.

https://t.co/eoWhZcs6SB

[The HIV Advanced Disease Consortium @hivadc]

#msf has developed an Advanced HIV Disease Toolkit | MSF SAMU https://t.co/mBRn60jELb

[The HIV Advanced Disease Consortium @hivadc]

Almost 800,000 HIV-related deaths in 2018.

https://t.co/Ijr0GWyfAK

#hivadc #AdvancedHIVdisease #HIVadvanceddisease

[The HIV Advanced Disease Consortium @hivadc]

@WHO has updated the Essential Diagnostics List.

https://t.co/qyJeEDSvCg

#HIVADC #AdvancedHIVdisease #HIVAdvanceddisease

[The HIV Advanced Disease Consortium @hivadc]

This pee test could save your life

https://t.co/LaqD97Gkm0

#hivadc #advancedHIVdisease #HIVadvanceddisease